We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

126 hedge funds and large institutions have $790M invested in Adverum Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

969% more call options, than puts

Call options by funds: $12.2M | Put options by funds: $1.14M

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

73% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 30

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

14% more capital invested

Capital invested by funds: $693M → $790M (+$97.1M)

9% more funds holding

Funds holding: 116 → 126 (+10)

0.83% more ownership

Funds ownership: 9.31% → 10.14% (+0.83%)

Holders
126
Holders Change
+10
Holders Change %
+8.62%
% of All Funds
2.78%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.15%
New
33
Increased
52
Reduced
30
Closed
19
Calls
$12.2M
Puts
$1.14M
Net Calls
+$11M
Net Calls Change
+$1.19M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$84.8M
2
VVM
Versant Venture Management
California
+$82.4M
3
ACA
Avoro Capital Advisors
New York
+$22.2M
4
DM
Deerfield Management
New York
+$21.7M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$10.4M
2
JP Morgan Chase
JP Morgan Chase
New York
-$6.06M
3
Renaissance Technologies
Renaissance Technologies
New York
-$4.33M
4
UBS Group
UBS Group
Switzerland
-$3.96M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$7.83M +$1.55M +13,265 +20%
UBS AM
27
UBS AM
Illinois
$7.37M +$5.72M +49,061 +186%
AG
28
Artal Group
Luxembourg
$5.86M +$7M +60,000 New
RPAM
29
Rhenman & Partners Asset Management
Sweden
$5.37M -$1.17M -10,000 -15%
SFSIG
30
San Francisco Sentry Investment Group
California
$4.69M – – –
Invesco
31
Invesco
Georgia
$3.85M +$2.65M +22,686 +135%
Charles Schwab
32
Charles Schwab
California
$3.76M +$650K +5,578 +17%
Millennium Management
33
Millennium Management
New York
$3.69M +$4.17M +35,764 +1,756%
SCM
34
Soleus Capital Management
Connecticut
$3.07M -$337K -2,890 -8%
Allianz Asset Management
35
Allianz Asset Management
Germany
$2.95M +$413K +3,539 +13%
Barclays
36
Barclays
United Kingdom
$2.63M -$2.27M -19,456 -42%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.53M +$233K +2,001 +8%
N
38
Nuveen
North Carolina
$2.42M +$373K +3,197 +15%
FLAM
39
First Light Asset Management
Minnesota
$2.37M +$2.83M +24,230 New
CS
40
Candriam SCA
Luxembourg
$2.25M – – –
CAC
41
Cowen and Company
New York
$2.14M -$209K -1,796 -8%
JP Morgan Chase
42
JP Morgan Chase
New York
$2.09M -$6.06M -51,958 -71%
AQR Capital Management
43
AQR Capital Management
Connecticut
$1.73M +$1.62M +13,876 +359%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$1.71M +$2.04M +17,501 New
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$1.64M +$92.6K +794 +5%
BCM
46
Burrage Capital Management
Massachusetts
$1.56M +$1.45M +12,421 +391%
EGI
47
EAM Global Investors
California
$1.34M +$1.6M +13,763 New
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$1.29M +$91.6K +786 +6%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.24M +$29.1K +250 +2%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.12M +$119K +1,020 +10%
1
2
3 4 5

ADVM Hedge Fund Activity: Q1 2020 in Review

126 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q1 2020, worth a combined $790M — up 14% from $693M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ADVM positions and 19 closed out — a net gain of 14 holders — while 52 added to existing stakes and 30 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $84.8M. The largest seller was OrbiMed, cutting an estimated $10.4M.

  • 126 institutional investors held Adverum Biotechnologies (ADVM) as of Q1 2020, up from 116 in Q4 2019.
  • Funds reported $790M of Adverum Biotechnologies stock for Q1 2020, up 14% quarter-over-quarter.
  • 33 funds opened new Adverum Biotechnologies positions in Q1 2020 and 19 closed out, a net change of +14 holders.
  • The largest Adverum Biotechnologies buyer in Q1 2020 was RA Capital Management, an estimated $84.8M added.
  • The largest Adverum Biotechnologies seller in Q1 2020 was OrbiMed, an estimated $10.4M sold.

Based on aggregated 13F filings for Q1 2020.